Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

How bad a woman's hair loss is doesn't always match how it affects her happiness and daily life.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

Stem cell therapy may help treat tough hair loss cases.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

The hepatitis B vaccine did not cause hair loss in the tested mice.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Two cosmetic lotions used day and night may be a good alternative to minoxidil for hair loss treatment with better cosmetic effects and tolerance.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

Dermoscopy helps diagnose and manage alopecia areata by showing specific hair changes.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.